Cold Chain Compliance:
Strengthening the Weakest Link. Biotech companies must ensure management programs are sound throughout the entire cold chain.
Life science organizations face new challenges due to mergers, acquisitions and expansion into emerging markets. Meeting these challenges requires the knowledge and capabilities to integrate activities across the product lifecycle, taking into account extended supply chains with additional complexity and risk. Identifying the cause of a disruption and its impact on the other links of the chain, and developing an effective solution, requires a holistic understanding of the entire supply chain.
Supply chains can best be described as systems. They are collections of inter-related, inter-dependent functions and processes that must operate in concert to transform inputs (materials and components) into defined outputs (products and services) in order to achieve the desired outcome: added value and financial gain for all participants. Specific functions are performed at the ‘link’ level, with the weakest link in the chain being the constraint — the limiting factor in the chain.
Taking this systems approach, Tunnell’s professionals use proven methodologies that combine the principles of Lean and Six Sigma and the Theory of Constraints to identify areas of risk and constraint, to develop sustainable solutions to increase throughput, and to reduce cost and risk. Recognizing the uniqueness of each supply chain environment, our teams work with internal and external stakeholders to meet the challenges of global manufacturing and distribution. These could include:
Established in 1962, Tunnell Consulting has worked across the life science spectrum and all of the functions that comprise the product life cycle from concept to consumption. Our teams of highly credentialed subject matter experts can provide the experience and expertise required to manage these functions across an 'extended-enterprise' of suppliers, contract research and development, manufacturing and distribution.
Strengthening the Weakest Link. Biotech companies must ensure management programs are sound throughout the entire cold chain.